Date: January 21 - 22, 2022

Friday, January 21, 2022 - 2:00 PM - 5:00 PM
Saturday, January 22, 2022 - 10:00 AM - 2:00 PM
*All times listed in EST

Featured Faculty:

Jonathan Kay, MD
UMass Memorial Medical Center
Worcester, Massachusetts

Sergio Schwartzman, MD
New York-Presbyterian Hospital
Hospital for Special Surgery/Weill Cornell Medical Center
New York, NY

Monica Schwartzman, MD
Hospital for Special Surgery/Weill Cornell Medical Center
New York, NY

Vibeke Strand, MD
Stanford University
Palo Alto, CA

Kevin Winthrop, MD, MPH
Oregon Health and Science University
Portland, Oregon

Target Audience:

This activity has been designed to meet the educational needs of rheumatologists, physicians, physician assistants, and nurse practitioners involved in the care of patients with rheumatic disease.

Goal Statement:

The goal of this program is to provide important clinical data on issues related to the management of the rheumatic disease.

Educational Objectives:

Upon completion of this educational activity, participants should be able to:

  • Review data on the prevalence of rheumatic diseases
  • Describe the progressive nature and detrimental effects of untreated rheumatic diseases
  • Discuss updates in diagnosis, classification and treatment guidelines and demonstrate strategies to incorporate these guidelines into practice
  • Analyze recently approved and emerging treatment options, including a review of their safety and efficacy through analysis of how new agents are improving patient care
  • Identify and analyze any "hot topics" in specific areas of rheumatic disease (such as the use of biosimilars, new treatments for psoriatic disease, vasculitis, gout, and drugs in development)

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation and MOC:

Purdue University College of Pharmacy designates this educational activity for a maximum of 5.25 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant financial relationships with ineligible companies related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, staff and reviewers of Focus Medical Communications and Purdue University College of Pharmacy have no relationships to disclose.

Accredited by:

This program is supported by educational grants from Abbvie, Amgen, Janssen Biotech Inc.